Related references
Note: Only part of the references are listed.Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS
Johanna Oechtering et al.
ANNALS OF NEUROLOGY (2022)
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series
Mattia Fonderico et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
Johanna Oechtering et al.
ANNALS OF NEUROLOGY (2021)
Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis
Omid Mirmosayyeb et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Low Serum Interleukin-10 Is an Independent Predictive Factor for the Risk of Second Event in Clinically Isolated Syndromes
Yuzhen Wei et al.
FRONTIERS IN NEUROLOGY (2019)
Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients
Zhile Bai et al.
FRONTIERS IN NEUROSCIENCE (2019)
Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients
Bonaventura Casanova et al.
NEUROLOGICAL SCIENCES (2018)
Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans
Rachel E. Ventura et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis
Tomas Uher et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans
Rachel E. Ventura et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis
Tomas Uher et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Incidence and prevalence of multiple sclerosis in Europe: a systematic review
Elaine Kingwell et al.
BMC NEUROLOGY (2013)
Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes
Maria Jose Magraner et al.
NEURORADIOLOGY (2012)
Onset symptoms as predictors of mortality and disability in multiple sclerosis
Barbara R. Visscher et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
T2 lesions and rate of progression of disability in multiple sclerosis
J. P. Mostert et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment
N. Garcia-Barragan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis
M. Thangarajh et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Influence of oligoclonal IgM specificity in multiple sclerosis disease course
L. M. Villar et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis
A Minneboo et al.
ARCHIVES OF NEUROLOGY (2004)
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process
C Confavreux et al.
BRAIN (2003)
Low interleukin-10 production is associated with higher disability and MRI lesion load in secondary progressive multiple sclerosis
HF Petereit et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)